Dynamic Prediction of 5-year Overall Survival in Stage I,II,III Colon Cancer Patients

被引：0
|
作者：
Battagello, J. [1 ]
Capelli, G. [2 ]
Restivo, A. [3 ]
Bao, Q. [2 ]
Deidda, S. [3 ]
Zorcolo, L. [3 ]
Pucciarelli, S. [2 ]
Zorzi, M. [1 ]
Spolverato, G. [2 ]
机构：
[1] Azienda Zero, Veneto Tumor Registry, Padua, Italy
[2] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Surg Clin 1, Padua, Italy
[3] Univ Cagliari, Cagliari, Italy
来源：
ANNALS OF SURGICAL ONCOLOGY | 2021年 / 28卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P88
引用
收藏
页码：S78 / S79
页数：2
相关论文
共 50 条
  • [21] Population-based assessment of disease-free survival (DFS) as a surrogate endpoint (SE) of 5-year overall survival (5Y OS) in stage I-III rectal (RC) and colon cancer (CC).
    Lee-Ying, Richard M.
    Yin, Yaling
    Lim, Howard John
    Cheung, Winson Y.
    Kennecke, Hagen F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [22] Immunohistochemical subtype and its relationship with 5-year overall survival in breast cancer patients
    Aldaz-Roldan, Pablo
    Pardo-Vasquez, Diego F.
    Chamba-Morales, Geanella N.
    Aguirre-Reyes, Daniel F.
    Castillo-Calvas, Johana M.
    Noblecilla-Arevalo, Gabriela
    ECANCERMEDICALSCIENCE, 2023, 17
  • [23] Extensive Inguinal Lymphadenectomy Improves Overall 5-Year Survival in Penile Cancer Patients
    Johnson, Timothy V.
    Hsiao, Wayland
    Delman, Keith A.
    Jani, Ashesh B.
    Brawley, Otis W.
    Master, Viraj A.
    CANCER, 2010, 116 (12) : 2960 - 2966
  • [24] The effect of chemotherapy on overall survival of stage II colon cancer.
    Omaira, M.
    Mozayen, M.
    Katato, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] 5-YEAR SURVIVAL AFTER EXTENDED RESECTION OF COLON CANCER
    GARDNER, B
    JOURNAL OF SURGICAL ONCOLOGY, 1987, 34 (04) : 258 - 261
  • [26] Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods
    Obrzut, Bogdan
    Kusy, Maciej
    Semczuk, Andrzej
    Obrzut, Marzanna
    Kluska, Jacek
    BMC CANCER, 2017, 17
  • [27] Development and Internal Validation of a Nomogram-Based Model to Predict Three-Year and Five-Year Overall Survival in Patients with Stage II/III Colon Cancer
    Ren, Dan
    Wang, Wen-Ling
    Wang, Gang
    Chen, Wei-Wei
    Li, Xiao-Kai
    Li, Guo-Dong
    Dong, Hong-Min
    Chen, Wang-Hua
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 225 - 236
  • [28] The role of cancer-related inflammation for prediction of poor survival in postmenopausal female patients with stage II/III colon cancer
    Zengin, Mehmet
    Karahan, Irfan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 85
  • [29] Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
    van den Broek, Evert
    Krijgsman, Oscar
    Sie, Daoud
    Tijssen, Marianne
    Mongera, Sandra
    van de Wiel, Mark A.
    Belt, Eric J. Th.
    den Uil, Sjoerd H.
    Bril, Herman
    Stockmann, Hein B. A. C.
    Ylstra, Bauke
    Carvalho, Beatriz
    Meijer, Gerrit A.
    Fijneman, Remond J. A.
    ONCOTARGET, 2016, 7 (45) : 73876 - 73887
  • [30] Incomplete 5-FU based adjuvant chemotherapy in patients with stage III colon cancer significantly prolongs overall survival
    Hoffmann, Martin
    Ogbonnaya, Lucky
    Benecke, Claudia
    Braun, Ruediger
    Zimmermann, Markus
    Schloericke, Erik
    Keck, Tobias
    INTERNATIONAL JOURNAL OF SURGERY OPEN, 2018, 14 : 19 - 26
12345